Vertex Pharmaceuticals traded at $440.37 this Tuesday May 21st, decreasing $5.32 or 1.19 percent since the previous trading session. Looking back, over the last four weeks, Vertex Pharmaceuticals lost 10.25 percent. Over the last 12 months, its price rose by 29.53 percent. Looking ahead, we forecast Vertex Pharmaceuticals to be priced at 433.25 by the end of this quarter and at 420.76 in one year, according to Trading Economics global macro models projections and analysts expectations.